USOR 20189

Avavilable at 1 location

Anal Cancer
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

United in Healing with The US Oncology Network - Maryland Oncology Hematology